In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.

Autor: Lund, Thomas, Gundesen, Michael Tveden, Juul Vangsted, Annette, Helleberg, Carsten, Haukås, Einar, Silkjær, Trine, Asmussen, Jon Thor, Manuela Teodorescu, Elena, Amdi Jensen, Bo, Schmidt Slørdahl, Tobias, Nahi, Hareth, Waage, Anders, Abildgaard, Niels, Schjesvold, Fredrik

Publikováno v: Blood Cancer Journal; 4/15/2024, Vol. 14 Issue 1, p1-5, 5p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Interferon-Alpha in the Treatment of Multiple Myeloma

Autor: Liane Khoo, Teh, Juul Vangsted, Annette, Joshua, Douglas, Gibson, John

Publikováno v: Current Drug Targets; March 2011, Vol. 12 Issue: 3 p437-446, 10p

Author Correction: Germline variants at SOHLH2 influence multiple myeloma risk.

Autor: Duran-Lozano L; Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden., Thorleifsson G; deCODE genetics, Sturlugata 8, IS-101, Reykjavik, Iceland., Lopez de Lapuente Portilla A; Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden., Niroula A; Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden.; Broad Institute, 415 Main Street, Cambridge, MA, 02124, USA., Went M; Division of Genetics and Epidemiology, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK., Thodberg M; Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden., Pertesi M; Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden., Ajore R; Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden., Cafaro C; Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden., Olason PI; deCODE genetics, Sturlugata 8, IS-101, Reykjavik, Iceland., Stefansdottir L; deCODE genetics, Sturlugata 8, IS-101, Reykjavik, Iceland., Bragi Walters G; deCODE genetics, Sturlugata 8, IS-101, Reykjavik, Iceland., Halldorsson GH; deCODE genetics, Sturlugata 8, IS-101, Reykjavik, Iceland., Turesson I; Hematology Clinic, Lund University Hospital, 221 85, Lund, Sweden., Kaiser MF; Division of Genetics and Epidemiology, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK., Weinhold N; Department of Internal Medicine V, University Hospital of Heidelberg, 69120, Heidelberg, Germany., Abildgaard N; Hematology Research Unit, Department of Clinical Research, University of Southern Denmark and Department of Hematology, Odense University Hospital, Odense, Denmark., Andersen NF; Department of Haematology, Aarhus University Hospital, 8200, Aarhus N, Denmark., Mellqvist UH; Södra Älvsborgs Sjukhus Borås, Borås, Sweden., Waage A; Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Department of Hematology, and Biobank1, St Olavs hospital, Trondheim, Norway., Juul-Vangsted A; Department of Haematology, University Hospital of Copenhagen at Rigshospitalet, Blegdamsvej 9, DK-2100, Copenhagen, Denmark., Thorsteinsdottir U; deCODE genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Hansson M; Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden.; Hematology Clinic, Lund University Hospital, 221 85, Lund, Sweden., Houlston R; Division of Genetics and Epidemiology, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK., Rafnar T; deCODE genetics, Sturlugata 8, IS-101, Reykjavik, Iceland., Stefansson K; deCODE genetics, Sturlugata 8, IS-101, Reykjavik, Iceland.; Faculty of Medicine, University of Iceland, Reykjavik, Iceland., Nilsson B; Hematology and Transfusion Medicine, Department of Laboratory Medicine, 221 84, Lund, Sweden. bjorn.nilsson@med.lu.se.; Broad Institute, 415 Main Street, Cambridge, MA, 02124, USA. bjorn.nilsson@med.lu.se.

Publikováno v: Blood cancer journal [Blood Cancer J] 2021 Nov 16; Vol. 11 (11), pp. 181. Date of Electronic Publication: 2021 Nov 16.